vs
Encompass Health Corp（EHC）与托罗公司（TTC）财务数据对比。点击上方公司名可切换其他公司
Encompass Health Corp的季度营收约是托罗公司的1.4倍（$1.5B vs $1.1B），Encompass Health Corp净利率更高（9.5% vs 4.7%，领先4.7%），Encompass Health Corp同比增速更快（9.9% vs -2.2%），托罗公司自由现金流更多（$207.2M vs $116.7M），过去两年Encompass Health Corp的营收复合增速更高（8.3% vs -8.1%）
Encompass Health Corp前身为Amcare及HealthSouth，总部位于美国阿拉巴马州伯明翰，是美国规模最大的住院康复服务提供商，在39个州及波多黎各拥有173家住院康复医院，为中风、神经系统疾病、心肺病症、脑损伤等患者提供专业康复诊疗服务。
托罗公司是一家总部位于美国明尼苏达州明尼阿波利斯郊区布卢明顿的企业，专注于设计、生产及销售割草机、吹雪机、灌溉系统配件等产品，广泛覆盖商业、民用、农业及公共部门等多个领域的使用需求。
EHC vs TTC — 直观对比
营收规模更大
EHC
是对方的1.4倍
$1.1B
营收增速更快
EHC
高出12.1%
-2.2%
净利率更高
EHC
高出4.7%
4.7%
自由现金流更多
TTC
多$90.5M
$116.7M
两年增速更快
EHC
近两年复合增速
-8.1%
损益表 — Q4 FY2025 vs Q3 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $1.5B | $1.1B |
| 净利润 | $146.1M | $53.5M |
| 毛利率 | — | 33.7% |
| 营业利润率 | 16.7% | 5.7% |
| 净利率 | 9.5% | 4.7% |
| 营收同比 | 9.9% | -2.2% |
| 净利润同比 | 20.8% | -55.2% |
| 每股收益（稀释后） | $1.43 | $0.54 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收EHCTTC
| Q4 25 | $1.5B | — | ||
| Q3 25 | $1.5B | $1.1B | ||
| Q2 25 | $1.5B | $1.3B | ||
| Q1 25 | $1.5B | $995.0M | ||
| Q4 24 | $1.4B | — | ||
| Q3 24 | $1.4B | $1.2B | ||
| Q2 24 | $1.3B | $1.3B | ||
| Q1 24 | $1.3B | $1.0B |
净利润EHCTTC
| Q4 25 | $146.1M | — | ||
| Q3 25 | $126.5M | $53.5M | ||
| Q2 25 | $142.1M | $136.8M | ||
| Q1 25 | $151.5M | $52.8M | ||
| Q4 24 | $120.9M | — | ||
| Q3 24 | $108.2M | $119.3M | ||
| Q2 24 | $114.1M | $144.8M | ||
| Q1 24 | $112.5M | $64.9M |
毛利率EHCTTC
| Q4 25 | — | — | ||
| Q3 25 | — | 33.7% | ||
| Q2 25 | — | 33.1% | ||
| Q1 25 | — | 33.7% | ||
| Q4 24 | — | — | ||
| Q3 24 | — | 34.8% | ||
| Q2 24 | — | 33.6% | ||
| Q1 24 | — | 34.4% |
营业利润率EHCTTC
| Q4 25 | 16.7% | — | ||
| Q3 25 | 14.9% | 5.7% | ||
| Q2 25 | 16.2% | 13.3% | ||
| Q1 25 | 16.4% | 7.8% | ||
| Q4 24 | 14.3% | — | ||
| Q3 24 | 13.6% | 12.8% | ||
| Q2 24 | 14.3% | 13.9% | ||
| Q1 24 | 13.6% | 8.8% |
净利率EHCTTC
| Q4 25 | 9.5% | — | ||
| Q3 25 | 8.6% | 4.7% | ||
| Q2 25 | 9.7% | 10.4% | ||
| Q1 25 | 10.4% | 5.3% | ||
| Q4 24 | 8.6% | — | ||
| Q3 24 | 8.0% | 10.3% | ||
| Q2 24 | 8.8% | 10.7% | ||
| Q1 24 | 8.5% | 6.5% |
每股收益（稀释后）EHCTTC
| Q4 25 | $1.43 | — | ||
| Q3 25 | $1.24 | $0.54 | ||
| Q2 25 | $1.39 | $1.37 | ||
| Q1 25 | $1.48 | $0.52 | ||
| Q4 24 | $1.18 | — | ||
| Q3 24 | $1.06 | $1.14 | ||
| Q2 24 | $1.12 | $1.38 | ||
| Q1 24 | $1.10 | $0.62 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $72.2M | — |
| 总债务越低越好 | $2.4B | $1.0B |
| 股东权益账面价值 | $2.4B | $1.4B |
| 总资产 | $7.1B | $3.5B |
| 负债/权益比越低杠杆越低 | 1.00× | 0.73× |
8季度趋势，按日历期对齐
现金及短期投资EHCTTC
| Q4 25 | $72.2M | — | ||
| Q3 25 | $48.7M | — | ||
| Q2 25 | $99.1M | — | ||
| Q1 25 | $95.8M | — | ||
| Q4 24 | $85.4M | — | ||
| Q3 24 | $147.8M | — | ||
| Q2 24 | $154.4M | — | ||
| Q1 24 | $134.4M | — |
总债务EHCTTC
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | $1.0B | ||
| Q2 25 | $2.3B | $1.1B | ||
| Q1 25 | $2.3B | $1.1B | ||
| Q4 24 | $2.4B | — | ||
| Q3 24 | $2.3B | $991.9M | ||
| Q2 24 | $2.7B | $1.0B | ||
| Q1 24 | $2.7B | $1.2B |
股东权益EHCTTC
| Q4 25 | $2.4B | — | ||
| Q3 25 | $2.4B | $1.4B | ||
| Q2 25 | $2.3B | $1.5B | ||
| Q1 25 | $2.2B | $1.5B | ||
| Q4 24 | $2.1B | — | ||
| Q3 24 | $2.0B | $1.6B | ||
| Q2 24 | $1.8B | $1.7B | ||
| Q1 24 | $1.7B | $1.5B |
总资产EHCTTC
| Q4 25 | $7.1B | — | ||
| Q3 25 | $6.9B | $3.5B | ||
| Q2 25 | $6.8B | $3.8B | ||
| Q1 25 | $6.6B | $3.7B | ||
| Q4 24 | $6.5B | — | ||
| Q3 24 | $6.5B | $3.7B | ||
| Q2 24 | $6.4B | $3.9B | ||
| Q1 24 | $6.2B | $3.8B |
负债/权益比EHCTTC
| Q4 25 | 1.00× | — | ||
| Q3 25 | 1.01× | 0.73× | ||
| Q2 25 | 1.02× | 0.74× | ||
| Q1 25 | 1.08× | 0.75× | ||
| Q4 24 | 1.14× | — | ||
| Q3 24 | 1.20× | 0.61× | ||
| Q2 24 | 1.46× | 0.62× | ||
| Q1 24 | 1.54× | 0.77× |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $346.0M | $225.8M |
| 自由现金流经营现金流 - 资本支出 | $116.7M | $207.2M |
| 自由现金流率自由现金流/营收 | 7.6% | 18.3% |
| 资本支出强度资本支出/营收 | 14.8% | 1.6% |
| 现金转化率经营现金流/净利润 | 2.37× | 4.22× |
| 过去12个月自由现金流最近4个季度 | $439.2M | $462.5M |
8季度趋势，按日历期对齐
经营现金流EHCTTC
| Q4 25 | $346.0M | — | ||
| Q3 25 | $270.8M | $225.8M | ||
| Q2 25 | $270.2M | $171.7M | ||
| Q1 25 | $288.6M | $-48.6M | ||
| Q4 24 | $278.8M | — | ||
| Q3 24 | $267.8M | $194.7M | ||
| Q2 24 | $217.4M | $227.3M | ||
| Q1 24 | $238.8M | $-92.2M |
自由现金流EHCTTC
| Q4 25 | $116.7M | — | ||
| Q3 25 | $83.7M | $207.2M | ||
| Q2 25 | $113.3M | $152.4M | ||
| Q1 25 | $125.5M | $-67.7M | ||
| Q4 24 | $80.1M | — | ||
| Q3 24 | $120.3M | $170.6M | ||
| Q2 24 | $60.5M | $206.9M | ||
| Q1 24 | $99.4M | $-111.3M |
自由现金流率EHCTTC
| Q4 25 | 7.6% | — | ||
| Q3 25 | 5.7% | 18.3% | ||
| Q2 25 | 7.8% | 11.6% | ||
| Q1 25 | 8.6% | -6.8% | ||
| Q4 24 | 5.7% | — | ||
| Q3 24 | 8.9% | 14.7% | ||
| Q2 24 | 4.6% | 15.3% | ||
| Q1 24 | 7.6% | -11.1% |
资本支出强度EHCTTC
| Q4 25 | 14.8% | — | ||
| Q3 25 | 12.7% | 1.6% | ||
| Q2 25 | 10.8% | 1.5% | ||
| Q1 25 | 11.2% | 1.9% | ||
| Q4 24 | 14.1% | — | ||
| Q3 24 | 10.9% | 2.1% | ||
| Q2 24 | 12.1% | 1.5% | ||
| Q1 24 | 10.6% | 1.9% |
现金转化率EHCTTC
| Q4 25 | 2.37× | — | ||
| Q3 25 | 2.14× | 4.22× | ||
| Q2 25 | 1.90× | 1.26× | ||
| Q1 25 | 1.90× | -0.92× | ||
| Q4 24 | 2.31× | — | ||
| Q3 24 | 2.48× | 1.63× | ||
| Q2 24 | 1.91× | 1.57× | ||
| Q1 24 | 2.12× | -1.42× |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
EHC
| Medicare | $1.0B | 66% |
| Medicare Advantage | $243.1M | 16% |
| Managed Care | $160.7M | 10% |
| Medicaid | $47.0M | 3% |
| Other Income Source | $44.8M | 3% |
| Other Thirdparty Payors | $11.2M | 1% |
| Workers Compensation | $7.6M | 0% |
| Patients | $4.6M | 0% |
TTC
| Equipment Products And Services | $815.7M | 72% |
| Residential Segment | $192.8M | 17% |
| Irrigation | $115.1M | 10% |
